Symbols / AORT Stock $37.03 +1.29% Artivion, Inc.
AORT (Stock) Chart
About
Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers On-X prosthetic aortic and mitral heart valves; On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters; Chord-X ePTFE sutures; pyrolytic carbon coating services; E-vita Open NEO, a hybrid stent graft; Arcevo, an LSA hybrid stent graft system; AMDS hybrid prosthesis; and NEXUS ONE, an endovascular stent graft system. It also provides NEXUS DUO, an aortic arch system; NEXUS TRE, a custom-made three branch graft; E-vita thoracic 3G, a stent graft system; E-xtra Design Engineering, a range of stent graft systems for the treatment of aortic vascular diseases, such as TAAA and Artivex; E-nside, a multibranch stent graft system; E-tegra, an AAA stent graft system; E-ventus BX and Tuva BX balloon-expandable peripheral stent grafts; and E-liac, a stent graft used to treat aneurysmal iliac arteries. In addition, the company offers synthetic vascular grafts that are used in open aortic and peripheral vascular surgical procedures; BioGlue, a surgical sealant; CryoValve SG pulmonary heart valve; CryoPatch SG pulmonary cardiac patch; SynerGraft, a decellularization technology; vascular preservation services; and PhotoFix, a bovine pericardial patch fixated. It markets its products and preservation services primarily to physicians through a direct sales team to hospitals and other healthcare facilities. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.
Stock Fundamentals
Scroll to Statements| Market Cap | 1.80B | Enterprise Value | 1.97B | Income | 9.76M | Sales | 441.33M | Book/sh | 9.37 | Cash/sh | 1.36 |
| Dividend Yield | — | Payout | 0.00% | Employees | 1800 | IPO | — | P/E | 176.33 | Forward P/E | 32.03 |
| PEG | 643.75 | P/S | 4.07 | P/B | 3.95 | P/C | — | EV/EBITDA | 36.56 | EV/Sales | 4.46 |
| Quick Ratio | 1.66 | Current Ratio | 3.53 | Debt/Eq | 57.67 | LT Debt/Eq | — | EPS (ttm) | 0.21 | EPS next Y | 1.16 |
| EPS Growth | — | Revenue Growth | 19.20% | Earnings | 2026-05-04 | ROA | 2.34% | ROE | 2.70% | ROIC | — |
| Gross Margin | 64.40% | Oper. Margin | 8.09% | Profit Margin | 2.21% | Shs Outstand | 48.50M | Shs Float | 45.40M | Short Float | 4.13% |
| Short Ratio | 4.28 | Short Interest | — | 52W High | 48.25 | 52W Low | 23.04 | Beta | 1.62 | Avg Volume | 448.61K |
| Volume | 224.81K | Target Price | $51.57 | Recom | Strong_buy | Prev Close | $36.56 | Price | $37.03 | Change | 1.29% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-04-10 | up | Ladenburg Thalmann | Neutral → Buy | $42 |
| 2026-04-07 | reit | Needham | Buy → Buy | $58 |
| 2026-02-13 | main | Canaccord Genuity | Buy → Buy | $48 |
| 2026-02-02 | reit | Needham | Buy → Buy | $58 |
| 2025-11-07 | main | Canaccord Genuity | Buy → Buy | $51 |
| 2025-11-07 | main | Citizens | Market Outperform → Market Outperform | $53 |
| 2025-11-07 | main | Needham | Buy → Buy | $58 |
| 2025-10-10 | main | JMP Securities | Market Outperform → Market Outperform | $47 |
| 2025-09-29 | main | Stifel | Buy → Buy | $46 |
| 2025-09-29 | main | Canaccord Genuity | Buy → Buy | $50 |
| 2025-08-22 | main | Needham | Buy → Buy | $50 |
| 2025-08-13 | down | Ladenburg Thalmann | Buy → Neutral | $39 |
| 2025-08-08 | main | Canaccord Genuity | Buy → Buy | $41 |
| 2025-08-08 | main | JMP Securities | Market Outperform → Market Outperform | $42 |
| 2025-08-08 | main | Stifel | Buy → Buy | $40 |
| 2025-08-08 | main | Needham | Buy → Buy | $45 |
| 2025-06-17 | init | Canaccord Genuity | — → Buy | $35 |
| 2025-05-06 | reit | JMP Securities | Market Outperform → Market Outperform | $33 |
| 2025-05-06 | reit | Needham | Buy → Buy | $32 |
| 2025-02-25 | reit | Citizens Capital Markets | Market Outperform → Market Outperform | $33 |
- Price Action Overview | Artivion posts 40% EPS miss below Street estimates - Performance Review - UBND thành phố Hải Phòng Wed, 22 Apr 2026 22
- Why Artivion (AORT) Stock Is Down Today - Yahoo Finance Mon, 06 Apr 2026 07
- Will FDA Approval Of NEXUS And Endospan Option Reshape Artivion's (AORT) Minimally Invasive Aortic Strategy - simplywall.st ue, 21 Apr 2026 04
- AORT (Artivion Inc.) shares fall 1.26% after Q4 2025 EPS lands 40% below consensus analyst estimates. - Inventory Turnover - Cổng thông tin điện tử Tỉnh Sơn La Wed, 22 Apr 2026 17
- Artivion (AORT) Gains Conviction List Spot with Strong Buy Ratin - GuruFocus Mon, 20 Apr 2026 16
- (AORT) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily Sun, 19 Apr 2026 12
- FDA approved a less invasive aortic arch device for high-risk patients - Stock Titan ue, 07 Apr 2026 07
- Artivion (AORT) Stock: Why It Matters This Year (-1.95%) 2026-04-16 - Crowd Risk Alerts - Cổng thông tin điện tử tỉnh Tây Ninh hu, 16 Apr 2026 19
- Artivion (AORT) soars 5.3%: Is further upside left in the stock? - MSN Wed, 08 Apr 2026 09
- Artivion (AORT) Stock Trades Down, Here Is Why - Yahoo Finance Fri, 13 Feb 2026 08
- Artivion (AORT) Stock Is Up, What You Need To Know - Yahoo Finance Wed, 17 Dec 2025 08
- Why Is Artivion (AORT) Stock Rocketing Higher Today - Yahoo Finance Fri, 08 Aug 2025 07
- How The Investment Story Is Shifting For Artivion (AORT) After Recent Analyst And FDA Updates - Yahoo Finance hu, 16 Apr 2026 23
- Is It Too Late To Consider Artivion (AORT) After A 161.6% Three Year Rally? - Yahoo Finance Wed, 01 Apr 2026 07
- Artivion Reports Fourth Quarter and Full Year 2025 Financial Results - PR Newswire hu, 12 Feb 2026 08
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
441.33
+13.59%
|
388.54
+9.75%
|
354.00
+12.82%
|
313.79
|
| Operating Revenue |
|
441.33
+13.59%
|
388.54
+9.75%
|
354.00
+12.82%
|
313.79
|
| Cost Of Revenue |
|
157.10
+12.41%
|
139.76
+11.96%
|
124.83
+12.19%
|
111.27
|
| Reconciled Cost Of Revenue |
|
157.10
+12.41%
|
139.76
+11.96%
|
124.83
+12.19%
|
111.27
|
| Gross Profit |
|
284.23
+14.25%
|
248.78
+8.55%
|
229.18
+13.16%
|
202.52
|
| Operating Expense |
|
257.48
+22.66%
|
209.91
-11.69%
|
237.68
+21.07%
|
196.32
|
| Research And Development |
|
30.99
+8.92%
|
28.45
-0.89%
|
28.71
-26.16%
|
38.88
|
| Selling General And Administration |
|
226.49
+24.82%
|
181.46
-13.17%
|
208.98
+32.73%
|
157.44
|
| Total Expenses |
|
414.58
+18.57%
|
349.66
-3.54%
|
362.51
+17.86%
|
307.59
|
| Operating Income |
|
26.75
-31.20%
|
38.87
+556.91%
|
-8.51
-237.20%
|
6.20
|
| Total Operating Income As Reported |
|
33.74
-13.19%
|
38.87
+577.01%
|
5.74
-7.40%
|
6.20
|
| EBITDA |
|
63.82
+25.22%
|
50.97
+90.26%
|
26.79
+4.31%
|
25.68
|
| Normalized EBITDA |
|
59.48
+8.87%
|
54.64
+335.74%
|
12.54
-51.18%
|
25.68
|
| Reconciled Depreciation |
|
22.46
-7.22%
|
24.20
+4.89%
|
23.08
+2.83%
|
22.44
|
| EBIT |
|
41.36
+54.55%
|
26.76
+620.79%
|
3.71
+14.60%
|
3.24
|
| Total Unusual Items |
|
4.34
+218.18%
|
-3.67
-125.75%
|
14.25
|
0.00
|
| Total Unusual Items Excluding Goodwill |
|
4.34
+218.18%
|
-3.67
-125.75%
|
14.25
|
0.00
|
| Special Income Charges |
|
4.34
+218.18%
|
-3.67
-125.75%
|
14.25
|
0.00
|
| Other Special Charges |
|
2.66
-27.39%
|
3.67
|
—
|
—
|
| Net Income |
|
9.77
+173.12%
|
-13.36
+56.47%
|
-30.69
-59.91%
|
-19.19
|
| Pretax Income |
|
14.78
+296.70%
|
-7.51
+65.19%
|
-21.59
-44.06%
|
-14.98
|
| Net Non Operating Interest Income Expense |
|
-25.82
+21.31%
|
-32.81
-35.46%
|
-24.22
-33.99%
|
-18.08
|
| Interest Expense Non Operating |
|
26.58
-22.45%
|
34.28
+35.49%
|
25.30
+38.82%
|
18.22
|
| Net Interest Income |
|
-25.82
+21.31%
|
-32.81
-35.46%
|
-24.22
-33.99%
|
-18.08
|
| Interest Expense |
|
26.58
-22.45%
|
34.28
+35.49%
|
25.30
+38.82%
|
18.22
|
| Interest Income Non Operating |
|
0.76
-47.99%
|
1.47
+36.21%
|
1.08
+632.65%
|
0.15
|
| Interest Income |
|
0.76
-47.99%
|
1.47
+36.21%
|
1.08
+632.65%
|
0.15
|
| Other Income Expense |
|
13.85
+202.03%
|
-13.58
-221.84%
|
11.14
+458.56%
|
-3.11
|
| Other Non Operating Income Expenses |
|
9.52
+196.05%
|
-9.91
-219.03%
|
-3.11
+0.06%
|
-3.11
|
| Tax Provision |
|
5.01
-14.25%
|
5.84
-35.80%
|
9.10
+116.35%
|
4.21
|
| Tax Rate For Calcs |
|
0.00
+61.43%
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
1.47
+290.78%
|
-0.77
-125.75%
|
2.99
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
9.77
+173.12%
|
-13.36
+56.47%
|
-30.69
-59.91%
|
-19.19
|
| Net Income From Continuing Operation Net Minority Interest |
|
9.77
+173.12%
|
-13.36
+56.47%
|
-30.69
-59.91%
|
-19.19
|
| Net Income From Continuing And Discontinued Operation |
|
9.77
+173.12%
|
-13.36
+56.47%
|
-30.69
-59.91%
|
-19.19
|
| Net Income Continuous Operations |
|
9.77
+173.12%
|
-13.36
+56.47%
|
-30.69
-59.91%
|
-19.19
|
| Normalized Income |
|
6.90
+165.98%
|
-10.46
+75.06%
|
-41.95
-118.57%
|
-19.19
|
| Net Income Common Stockholders |
|
9.76
+173.17%
|
-13.34
+56.37%
|
-30.57
-60.09%
|
-19.09
|
| Otherunder Preferred Stock Dividend |
|
0.01
+145.83%
|
-0.02
+80.49%
|
-0.12
-25.51%
|
-0.10
|
| Diluted EPS |
|
—
|
-0.32
+57.33%
|
-0.75
-56.25%
|
-0.48
|
| Basic EPS |
|
—
|
-0.32
+57.33%
|
-0.75
-56.25%
|
-0.48
|
| Basic Average Shares |
|
—
|
41.68
+2.29%
|
40.74
+1.78%
|
40.03
|
| Diluted Average Shares |
|
—
|
41.68
+2.29%
|
40.74
+1.78%
|
40.03
|
| Diluted NI Availto Com Stockholders |
|
9.76
+173.17%
|
-13.34
+56.37%
|
-30.57
-60.09%
|
-19.09
|
| Gain On Sale Of PPE |
|
7.00
|
0.00
-100.00%
|
14.25
|
0.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
884.80
+12.13%
|
789.10
-0.42%
|
792.40
+3.88%
|
762.80
|
| Current Assets |
|
358.08
+23.44%
|
290.08
+3.35%
|
280.67
+13.48%
|
247.33
|
| Cash Cash Equivalents And Short Term Investments |
|
64.91
+21.41%
|
53.46
-9.29%
|
58.94
+49.78%
|
39.35
|
| Cash And Cash Equivalents |
|
64.91
+21.41%
|
53.46
-9.29%
|
58.94
+49.78%
|
39.35
|
| Receivables |
|
103.68
+20.71%
|
85.89
+15.86%
|
74.14
+6.54%
|
69.58
|
| Accounts Receivable |
|
89.76
+12.96%
|
79.46
+10.68%
|
71.80
+16.14%
|
61.82
|
| Gross Accounts Receivable |
|
—
|
—
|
—
|
63.12
|
| Allowance For Doubtful Accounts Receivable |
|
—
|
—
|
—
|
-1.30
|
| Other Receivables |
|
13.92
+116.47%
|
6.43
+174.59%
|
2.34
-69.84%
|
7.76
|
| Inventory |
|
92.43
+15.87%
|
79.77
-2.70%
|
81.98
+10.07%
|
74.48
|
| Raw Materials |
|
36.35
+3.00%
|
35.30
-4.37%
|
36.91
+0.52%
|
36.72
|
| Work In Process |
|
17.13
+23.03%
|
13.93
+9.77%
|
12.69
+21.11%
|
10.48
|
| Finished Goods |
|
38.94
+27.48%
|
30.55
-5.67%
|
32.38
+18.67%
|
27.29
|
| Prepaid Assets |
|
—
|
—
|
—
|
—
|
| Current Deferred Assets |
|
54.53
+5.47%
|
51.70
+3.81%
|
49.80
+7.40%
|
46.37
|
| Other Current Assets |
|
42.54
+120.89%
|
19.26
+21.80%
|
15.81
-9.91%
|
17.55
|
| Total Non Current Assets |
|
526.71
+5.55%
|
499.02
-2.48%
|
511.73
-0.72%
|
515.46
|
| Net PPE |
|
99.69
+30.95%
|
76.13
-7.36%
|
82.18
+2.05%
|
80.53
|
| Gross PPE |
|
197.53
+19.50%
|
165.30
-1.08%
|
167.10
-1.05%
|
168.87
|
| Accumulated Depreciation |
|
-97.84
-9.73%
|
-89.17
-5.00%
|
-84.92
+3.87%
|
-88.34
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Buildings And Improvements |
|
19.93
|
0.00
|
—
|
—
|
| Machinery Furniture Equipment |
|
89.30
+20.10%
|
74.36
+0.25%
|
74.17
-6.85%
|
79.63
|
| Other Properties |
|
34.70
-12.65%
|
39.73
-9.35%
|
43.82
+4.69%
|
41.86
|
| Leases |
|
53.60
+4.65%
|
51.21
+4.29%
|
49.11
+3.64%
|
47.38
|
| Goodwill And Other Intangible Assets |
|
410.59
+3.33%
|
397.34
-5.30%
|
419.57
-1.57%
|
426.28
|
| Goodwill |
|
254.09
+5.45%
|
240.96
-2.58%
|
247.34
+1.52%
|
243.63
|
| Other Intangible Assets |
|
156.50
+0.07%
|
156.38
-9.20%
|
172.23
-5.70%
|
182.65
|
| Non Current Deferred Assets |
|
1.20
+12.45%
|
1.07
-1.75%
|
1.09
-17.28%
|
1.31
|
| Non Current Deferred Taxes Assets |
|
1.20
+12.45%
|
1.07
-1.75%
|
1.09
-17.28%
|
1.31
|
| Other Non Current Assets |
|
15.24
-37.76%
|
24.48
+175.28%
|
8.89
+21.19%
|
7.34
|
| Total Liabilities Net Minority Interest |
|
436.56
-14.88%
|
512.90
+0.45%
|
510.62
+6.72%
|
478.47
|
| Current Liabilities |
|
101.56
+51.98%
|
66.82
+15.49%
|
57.86
+16.48%
|
49.67
|
| Payables And Accrued Expenses |
|
48.23
+13.18%
|
42.61
+36.02%
|
31.33
+7.57%
|
29.12
|
| Payables |
|
23.53
+12.56%
|
20.91
+21.84%
|
17.16
+17.21%
|
14.64
|
| Accounts Payable |
|
16.04
-10.73%
|
17.97
+34.94%
|
13.32
+10.95%
|
12.00
|
| Current Accrued Expenses |
|
24.70
+13.77%
|
21.71
+53.19%
|
14.17
-2.17%
|
14.48
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
22.48
+22.58%
|
18.34
-1.99%
|
18.71
+35.52%
|
13.81
|
| Total Tax Payable |
|
7.49
+155.25%
|
2.93
-23.59%
|
3.84
+45.73%
|
2.63
|
| Current Debt And Capital Lease Obligation |
|
5.38
+1.70%
|
5.29
-2.63%
|
5.43
-0.02%
|
5.43
|
| Current Debt |
|
—
|
0.20
-86.56%
|
1.45
-9.76%
|
1.61
|
| Other Current Borrowings |
|
—
|
0.20
-86.56%
|
1.45
-9.76%
|
1.61
|
| Current Capital Lease Obligation |
|
5.38
+5.60%
|
5.09
+27.99%
|
3.98
+4.08%
|
3.82
|
| Other Current Liabilities |
|
25.47
+4268.44%
|
0.58
-75.61%
|
2.39
+82.16%
|
1.31
|
| Total Non Current Liabilities Net Minority Interest |
|
335.01
-24.90%
|
446.08
-1.47%
|
452.75
+5.59%
|
428.79
|
| Long Term Debt And Capital Lease Obligation |
|
252.24
-29.34%
|
356.97
+1.15%
|
352.91
+0.43%
|
351.40
|
| Long Term Debt |
|
215.11
-31.53%
|
314.15
+2.82%
|
305.53
-0.32%
|
306.50
|
| Long Term Capital Lease Obligation |
|
37.12
-13.30%
|
42.82
-9.63%
|
47.38
+5.53%
|
44.90
|
| Non Current Deferred Liabilities |
|
33.77
+19.93%
|
28.16
-1.58%
|
28.61
-4.52%
|
29.97
|
| Non Current Deferred Taxes Liabilities |
|
24.31
+20.44%
|
20.18
-7.63%
|
21.85
-10.81%
|
24.50
|
| Other Non Current Liabilities |
|
49.00
-19.60%
|
60.95
-14.44%
|
71.23
+50.19%
|
47.43
|
| Stockholders Equity |
|
448.23
+62.29%
|
276.20
-1.98%
|
281.78
-0.90%
|
284.33
|
| Common Stock Equity |
|
448.23
+62.29%
|
276.20
-1.98%
|
281.78
-0.90%
|
284.33
|
| Capital Stock |
|
0.49
+13.59%
|
0.43
+1.88%
|
0.43
+1.91%
|
0.42
|
| Common Stock |
|
0.49
+13.59%
|
0.43
+1.88%
|
0.43
+1.91%
|
0.42
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
49.33
+13.58%
|
43.43
+2.03%
|
42.57
+1.77%
|
41.83
|
| Ordinary Shares Number |
|
47.84
+14.06%
|
41.95
+2.10%
|
41.08
+1.83%
|
40.34
|
| Treasury Shares Number |
|
1.49
+0.00%
|
1.49
+0.00%
|
1.49
+0.00%
|
1.49
|
| Additional Paid In Capital |
|
516.60
+37.17%
|
376.61
+5.81%
|
355.92
+5.49%
|
337.38
|
| Retained Earnings |
|
-51.50
+15.94%
|
-61.27
-27.89%
|
-47.91
-178.25%
|
-17.22
|
| Gains Losses Not Affecting Retained Earnings |
|
-2.72
+89.09%
|
-24.93
-107.55%
|
-12.01
+44.42%
|
-21.61
|
| Treasury Stock |
|
14.65
+0.00%
|
14.65
+0.00%
|
14.65
+0.00%
|
14.65
|
| Other Equity Adjustments |
|
-2.72
+89.09%
|
-24.93
-107.55%
|
-12.01
+44.42%
|
-21.61
|
| Total Equity Gross Minority Interest |
|
448.23
+62.29%
|
276.20
-1.98%
|
281.78
-0.90%
|
284.33
|
| Total Capitalization |
|
663.35
+12.36%
|
590.35
+0.52%
|
587.31
-0.60%
|
590.83
|
| Working Capital |
|
256.53
+14.90%
|
223.26
+0.20%
|
222.81
+12.72%
|
197.66
|
| Invested Capital |
|
663.35
+12.33%
|
590.55
+0.30%
|
588.76
-0.62%
|
592.44
|
| Total Debt |
|
257.61
-28.89%
|
362.26
+1.09%
|
358.34
+0.42%
|
356.83
|
| Net Debt |
|
150.21
-42.42%
|
260.88
+5.18%
|
248.04
-7.71%
|
268.76
|
| Capital Lease Obligations |
|
42.50
-11.29%
|
47.91
-6.71%
|
51.36
+5.41%
|
48.72
|
| Net Tangible Assets |
|
37.65
+131.08%
|
-121.14
+12.08%
|
-137.79
+2.93%
|
-141.95
|
| Tangible Book Value |
|
37.65
+131.08%
|
-121.14
+12.08%
|
-137.79
+2.93%
|
-141.95
|
| Interest Payable |
|
4.82
-41.06%
|
8.17
+257.86%
|
2.28
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
39.88
+79.35%
|
22.24
+18.12%
|
18.82
+465.32%
|
-5.15
|
| Cash Flow From Continuing Operating Activities |
|
39.88
+79.35%
|
22.24
+18.12%
|
18.82
+465.32%
|
-5.15
|
| Net Income From Continuing Operations |
|
9.77
+173.12%
|
-13.36
+56.47%
|
-30.69
-59.91%
|
-19.19
|
| Depreciation Amortization Depletion |
|
22.46
-7.22%
|
24.20
+4.89%
|
23.08
+2.83%
|
22.44
|
| Depreciation And Amortization |
|
22.46
-7.22%
|
24.20
+4.89%
|
23.08
+2.83%
|
22.44
|
| Other Non Cash Items |
|
4.83
-38.08%
|
7.80
-78.48%
|
36.25
+15590.17%
|
-0.23
|
| Stock Based Compensation |
|
24.39
+71.22%
|
14.24
-1.25%
|
14.42
+16.83%
|
12.34
|
| Asset Impairment Charge |
|
4.90
+10.51%
|
4.43
-7.34%
|
4.79
+9.40%
|
4.37
|
| Deferred Tax |
|
0.04
+102.45%
|
-1.51
-9.10%
|
-1.39
+19.34%
|
-1.72
|
| Deferred Income Tax |
|
0.04
+102.45%
|
-1.51
-9.10%
|
-1.39
+19.34%
|
-1.72
|
| Operating Gains Losses |
|
-4.34
-218.18%
|
3.67
+125.75%
|
-14.25
|
—
|
| Change In Working Capital |
|
-22.16
-28.52%
|
-17.24
-28.87%
|
-13.38
+42.25%
|
-23.17
|
| Change In Receivables |
|
-7.27
+52.78%
|
-15.39
-280.12%
|
-4.05
+69.64%
|
-13.34
|
| Change In Inventory |
|
-15.28
-148.93%
|
-6.14
+57.26%
|
-14.36
-70.87%
|
-8.40
|
| Change In Prepaid Assets |
|
-1.80
+65.48%
|
-5.21
-1073.64%
|
0.54
+123.95%
|
-2.23
|
| Change In Payables And Accrued Expense |
|
2.18
-77.02%
|
9.50
+111.30%
|
4.50
+456.31%
|
0.81
|
| Change In Payable |
|
2.18
-77.02%
|
9.50
+111.30%
|
4.50
+456.31%
|
0.81
|
| Change In Account Payable |
|
2.18
-77.02%
|
9.50
+111.30%
|
4.50
+456.31%
|
0.81
|
| Investing Cash Flow |
|
-42.04
-49.15%
|
-28.19
-5515.14%
|
-0.50
+95.31%
|
-10.71
|
| Cash Flow From Continuing Investing Activities |
|
-42.04
-49.15%
|
-28.19
-5515.14%
|
-0.50
+95.31%
|
-10.71
|
| Capital Expenditure |
|
-39.04
-248.95%
|
-11.19
-14.73%
|
-9.75
+8.99%
|
-10.71
|
| Capital Expenditure Reported |
|
-39.04
-248.95%
|
-11.19
-14.73%
|
-9.75
+8.99%
|
-10.71
|
| Net Investment Purchase And Sale |
|
—
|
—
|
—
|
0.00
|
| Sale Of Investment |
|
—
|
—
|
—
|
0.00
|
| Net Business Purchase And Sale |
|
—
|
—
|
-5.00
|
0.00
|
| Purchase Of Business |
|
—
|
—
|
-5.00
|
0.00
|
| Net Intangibles Purchase And Sale |
|
—
|
—
|
—
|
-1.70
|
| Purchase Of Intangibles |
|
—
|
—
|
—
|
-1.70
|
| Net Other Investing Changes |
|
-3.00
+82.35%
|
-17.00
-283.78%
|
9.25
+644.44%
|
-1.70
|
| Financing Cash Flow |
|
11.28
+412.12%
|
2.20
+154.68%
|
0.86
+152.78%
|
-1.64
|
| Cash Flow From Continuing Financing Activities |
|
11.28
+412.12%
|
2.20
+154.68%
|
0.86
+152.78%
|
-1.64
|
| Net Issuance Payments Of Debt |
|
-2.46
-587.15%
|
-0.36
+93.25%
|
-5.30
-92.63%
|
-2.75
|
| Issuance Of Debt |
|
0.00
-100.00%
|
212.50
|
0.00
|
0.00
|
| Repayment Of Debt |
|
-2.46
+98.84%
|
-212.86
-3913.92%
|
-5.30
-92.63%
|
-2.75
|
| Long Term Debt Issuance |
|
0.00
-100.00%
|
212.50
|
0.00
|
0.00
|
| Long Term Debt Payments |
|
-0.21
+99.90%
|
-211.83
-7541.81%
|
-2.77
-0.69%
|
-2.75
|
| Net Long Term Debt Issuance |
|
-0.21
-131.39%
|
0.67
+124.13%
|
-2.77
-0.69%
|
-2.75
|
| Short Term Debt Issuance |
|
—
|
—
|
—
|
0.00
|
| Short Term Debt Payments |
|
-2.25
-119.08%
|
-1.03
+59.42%
|
-2.53
|
0.00
|
| Net Short Term Debt Issuance |
|
-2.25
-119.08%
|
-1.03
+59.42%
|
-2.53
|
0.00
|
| Net Common Stock Issuance |
|
0.00
|
0.00
+100.00%
|
-0.56
+68.86%
|
-1.79
|
| Common Stock Payments |
|
0.00
|
0.00
+100.00%
|
-0.56
+68.86%
|
-1.79
|
| Repurchase Of Capital Stock |
|
0.00
|
0.00
+100.00%
|
-0.56
+68.86%
|
-1.79
|
| Proceeds From Stock Option Exercised |
|
13.07
+128.25%
|
5.73
+44.83%
|
3.96
+17.43%
|
3.37
|
| Net Other Financing Charges |
|
0.67
+121.09%
|
-3.17
-214.25%
|
2.77
+703.92%
|
-0.46
|
| Changes In Cash |
|
9.12
+343.29%
|
-3.75
-119.54%
|
19.19
+209.60%
|
-17.51
|
| Effect Of Exchange Rate Changes |
|
2.32
+234.49%
|
-1.73
-530.92%
|
0.40
-78.30%
|
1.85
|
| Beginning Cash Position |
|
53.46
-9.29%
|
58.94
+49.78%
|
39.35
-28.47%
|
55.01
|
| End Cash Position |
|
64.91
+21.41%
|
53.46
-9.29%
|
58.94
+49.78%
|
39.35
|
| Free Cash Flow |
|
0.84
-92.41%
|
11.05
+21.77%
|
9.07
+157.18%
|
-15.87
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-03-04 View
- 42026-03-04 View
- 42026-03-04 View
- 42026-03-04 View
- 42026-03-04 View
- 42026-03-04 View
- 42026-03-03 View
- 42026-03-03 View
- 42026-03-03 View
- 42026-03-03 View
- 42026-03-03 View
- 42026-03-03 View
- 42026-02-25 View
- 42026-02-25 View
- 42026-02-25 View
- 42026-02-25 View
- 42026-02-25 View
- 42026-02-25 View
- 10-K2026-02-18 View
- 8-K2026-02-12 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|